Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma: A Literature Review and Treatment Perspectives

• Main Authors: Daniel M. Girardi (Author), Jana Priscila M. Pacífico (Author), Fernanda P. L. Guedes de Amorim (Author), Gustavo dos Santos Fernandes (Author), Marcela C. Teixeira (Author), Allan A. L. Pereira (Author)
• Format: Book
• Published: MDPI AG, 2020-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Advanced hepatocellular carcinoma is a prevalent and potentially aggressive disease. For more than a decade, treatment with sorafenib has been the only approved therapeutic approach. Moreover, no agent has been proven to prolong survival following the progression of disease after sorafenib treatment...